Prognostic impact of pericardial effusion in patients with acute myocarditis
European Heart Journal: Acute Cardiovascular Care · 29.10.2026 · 15 (10) · 741-751
DOI: 10.1093/ehjacc/zuag090 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift European Heart Journal: Acute Cardiovascular Care, online erschienen am 31.08.2026. Verfasst von Matthieu Proust und 24 weiteren Autor:innen. Beteiligte Einrichtung: Sorbonne Université, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital La Pitié-Salpêtrière, Département de Cardiologie, INSERM UMRS 1166-ICAN, …. Hauptthemen laut MEDLINE: Myocarditis, Pericardial Effusion, Registries. Die Arbeit nennt 21 Literaturangaben. Gefördert von: PHRA, FFC.
Abstract (Originalsprache)
Aims
Recent Guidelines of the European Society of Cardiology have introduced the concept of Inflammatory Myocardial and Pericardial Syndrome (IMPS), a unified entity encompassing both myocarditis and pericarditis. This framework reflects the continuum between these conditions in term of anatomy, shared aetiologies, and a common diagnostic approach. This study sought (i) to describe factors associated with pericardial involvement; (ii) to compare the outcomes of patients hospitalized for proven acute myocarditis (AM) with or without pericardial effusion; (iii) to identify the independent correlates of clinical outcome. Methods and results This is an observational ambispective cohort study based on the AMPHIBIA registry (Assistance Publique—Hôpitaux de Paris/ACTION Study Group), including patients hospitalized for proven AM between August 2008 and December 2024 at La Pitié Salpêtrière Hospital, Paris, France. Patients were stratified into two groups based on the presence of pericardial effusion on admission transthoracic echocardiography, ranging from minimal effusions to tamponade. The main composite outcome was defined as the occurrence of all-cause death, temporary mechanical circulatory support, severe ventricular arrhythmia, and heart transplantation, at the longest follow-up, up to 7 years. A total of 581 patients with AM were included [follow-up 3.7 (1.3–7.3) years]. Among them, 134 (23%) patients presented with pericardial effusion and 447 (77%) patients without. Four independent variables were associated with pericardial effusion at admission: left ventricular (LV) dysfunction, immunological myocarditis, elevated CRP, and fever. The occurrence of the composite event was significantly higher in patients with pericardial effusion compared to those without [38.1% vs. 15.7%, hazard ratio (HR) 2.69, 95% confidence interval (CI) (1.88–3.86), P < 0.001]. This difference was observed regardless of pericardial effusion size. After multivariable analysis, pericardial effusion was independently associated with the main composite outcome [HR 1.99 (1.32–3.00), P < 0.001.
Conclusion
This study characterizes the phenotypes and outcomes of patients hospitalized for an AM, with and without pericardial effusion. Pericardial involvement was associated with LV dysfunction, immunological myocarditis, elevated CRP, and fever and was linked to a markedly higher risk of the composite outcome, remaining an independent predictor of adverse events. Differentiating these two phenotypes may provide physicians with valuable guidance for managing therapy in these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Sorbonne Université, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital La Pitié-Salpêtrière, Département de Cardiologie, INSERM UMRS 1166-ICAN, ACTION Study Group, F-75013 Paris, France.
- Sorbonne Université, AP-HP, Hôpital La Pitié-Salpêtrière, Département de Génétique, DMU BioGem-Unité Fonctionnelle de Cardiogénétique et Myogénétique Moléculaire et Cellulaire, CRMR, Maladies Cardiaques Héréditaires ou…
- Sorbonne Université, AP-HP, Hôpital La Pitié-Salpêtrière, Unité D'Imagerie Cardiovasculaire et Thoracique (ICT), Paris, France.
- Sorbonne Université, AP-HP, Hôpital La Pitié-Salpêtrière, Institut E3M, Service de Médecine Interne 2, Centre de Référence National Lupus Systémique, Syndrome des Anticorps Anti-Phospholipides et Autres Maladies Auto-Im…
- Sorbonne Université, AP-HP, Hôpital La Pitié-Salpêtrière, Service de Médecine Intensive Réanimation, Paris, France.
- Sorbonne Université, AP-HP, Hôpital La Pitié-Salpêtrière, Service de Chirurgie Cardio-Thoracique, Paris, France.
ORCID-Profile: Matthieu Proust, Florent Huang, Marie Dupuy, Estelle Gandjbakhch, Philippe Charron, Alban Redheuil, Francesco Ravera, Benjamin Bertin, Fleur Cohen-Aubart, Matthias Papo, Guillaume Hekimian, Guillaume Lebreton, Paul Guedeney, Éric Vicaut, Johanne Silvain, Mathieu Kerneis
Förderung
- PHRA
- FFC
Zitieren
APA
Proust, M., Huang, F., Zeitouni, M., Hammoudi, N., Dupuy, M., Gandjbakhch, E., Charron, P., Redheuil, A., Ravera, F., Bertin, B., Cohen-Aubart, F., Papo, M., Hekimian, G., Chommeloux, J., Schmidt, M., Combes, A., Juvin, C., Leprince, P., Lebreton, G., …, & ACTION Study Group (2026). Prognostic impact of pericardial effusion in patients with acute myocarditis. European Heart Journal: Acute Cardiovascular Care, 15(10), 741-751. https://doi.org/10.1093/ehjacc/zuag090
Vancouver
Proust M, Huang F, Zeitouni M, Hammoudi N, Dupuy M, Gandjbakhch E, et al. Prognostic impact of pericardial effusion in patients with acute myocarditis. European Heart Journal: Acute Cardiovascular Care. 2026;15(10):741-751. doi:10.1093/ehjacc/zuag090
BibTeX
@article{Proust2026,
author = {Proust, Matthieu and Huang, Florent and Zeitouni, Michel and Hammoudi, Nadjib and Dupuy, Marie and Gandjbakhch, Estelle and Charron, Philippe and Redheuil, Alban and Ravera, Francesco and Bertin, Benjamin and Cohen-Aubart, Fleur and Papo, Matthias and Hekimian, Guillaume and Chommeloux, Juliette and Schmidt, Matthieu and Combes, Alain and Juvin, Charles and Leprince, Pascal and Lebreton, Guillaume and Guedeney, Paul and Vicaut, Éric and Silvain, Johanne and Montalescot, Gilles and Kerneis, Mathieu and ACTION Study Group, ACTION Study Group},
title = {Prognostic impact of pericardial effusion in patients with acute myocarditis},
journal = {European Heart Journal: Acute Cardiovascular Care},
year = {2026},
volume = {15},
number = {10},
pages = {741--751},
doi = {10.1093/ehjacc/zuag090}
}
EUVIMED